search
Back to results

CiNPT for Abdominoplasties in Post-bariatric Patients Study (CAPS)

Primary Purpose

Obesity, Morbid, Obesity, Obesity, Abdominal

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
ciNPT group
Control group
Sponsored by
Azienda Ospedaliera, Ospedale Civile di Legnano
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Obesity, Morbid focused on measuring Closed-incision negative pressure therapy, Negative pressure wound therapy, Wound care, Surgical incision, Wound complication, Dehiscence, Surgical Site Infection, Seroma, Hematoma, Wound Healing, Inflammation, Incisional Wound, Abdominoplasty, Abdominal panniculectomy, Body contouring

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • previous bariatric surgery for weight loss
  • candidate for/undergoing an abdominal panniculectomy (abdominoplasty)
  • Residual BMI >30 kg/m2 at the time of the operation
  • Evidence of pannus (abdominal) ptosis (Pittsburgh Rating Scale >2)
  • Lipodystrophy and inelasticity of the skin
  • Presence at the time of surgery of at least one local risk factor (e.g. a history or the presence of local complications such as skin blistering, recurrent erythema, panniculitis, or chronic infection; history of abdominal hernia or need for abdominal hernia repair) OR one systemic risk factor (diabetes, smoking habit, serum proteins below 6g/dL).

Exclusion Criteria:

  • Severe systemic co-morbidities (defined as ASA III or higher)
  • Malignant tumors
  • Conditions or medications affecting wound healing (e.g. steroidal drugs or keloids)
  • Known allergies to components of the treatment
  • Presence of severe local cutaneous complications (open wounds, extensive infections) at the time of surgery.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Sham Comparator

    Arm Label

    ciNPT group

    Control group

    Arm Description

    Subjects will receive post-operative incisional wound care by ciNPT (125 mmHg, continuous suction) for the first 7 days after surgery.

    Subjects will receive post-operative incisional wound care by standard non-adherent surgical dressing (vaseline petrolatum gauze),

    Outcomes

    Primary Outcome Measures

    Rate of post-surgical local complications
    The change in post-surgical local complications (Skin blistering/necrosis, Surgical Site Infections, hematoma, seroma, need for re-operation) through 30 days after surgery.

    Secondary Outcome Measures

    Time-to-heal
    A change in time (days) to complete wound closure for treated groups vs. controls.
    Scar quality: Vancouver Scar Scale
    A change in the macroscopic quality of scars at a 30 and 90 days follow up (measured with the Vancouver Scar Scale-VSS [Score range: 0-13, lower scores being a better outcome]).
    Medical costs
    A change in direct medical costs (considering cumulative costs related to: hospitalization, standard and additional post-operative care, additional surgical and medical care for complications) in the first 60 days after surgery.

    Full Information

    First Posted
    December 20, 2019
    Last Updated
    December 30, 2019
    Sponsor
    Azienda Ospedaliera, Ospedale Civile di Legnano
    Collaborators
    Acelity
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04214236
    Brief Title
    CiNPT for Abdominoplasties in Post-bariatric Patients Study
    Acronym
    CAPS
    Official Title
    Evaluation of ciNPT Effects on Healing and Post-surgical Complications in High-risk Post- Bariatric Patients Undergoing Body-contouring Abdominoplasty: a Monocentric Prospective RCT
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    December 2019
    Overall Recruitment Status
    Unknown status
    Study Start Date
    February 1, 2020 (Anticipated)
    Primary Completion Date
    November 1, 2022 (Anticipated)
    Study Completion Date
    January 31, 2023 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Azienda Ospedaliera, Ospedale Civile di Legnano
    Collaborators
    Acelity

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    Yes
    Product Manufactured in and Exported from the U.S.
    Yes
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The overarching goal of this research is to assess whether the post-operative use of closed-incision Negative Pressure Therapy (ciNPT) accelerates healing of surgical wounds, improves surgical outcomes, and reduces the rate of local complications in high-risk, obese, post-bariatric patients undergoing abdominal body-contouring procedures (abdominal panniculectomy or "abdominoplasty") compared to standard wound care. The investigators postulate that ciNPT can cost-effectively improve outcomes and standard of post-surgical care in this specific category of patients. This hypothesis will be tested through a prospective, interventional, case-control, randomized clinical trial.
    Detailed Description
    In the United States (US) 37% of the adult population is obese and 5% is considered morbidly obese. Similar trends have been observed in Europe and more recently in Asia. A large number of obese patients seeks treatment through bariatric surgery or diet-lifestyle changes. The resulting massive loss of weight leaves patients with an excess cutaneous tissue, requiring body-contouring procedures. In the US 85% of post-bariatric patients seek body-contouring surgeries. Due to systemic and local factors, these procedures show a rate of local complications as high as 68-80%, significantly prolonging hospitalization and increasing treatment-related costs. Several clinical studies have shown that external suction (Closed Incision Negative-Pressure Therapy, ciNPT) can accelerate closure of surgical wounds in patients at high-risk for impaired/delayed healing and can significantly reduce the rate of local complications. The investigators believe that ciNPT might significantly decrease the rate of minor local complications in post-bariatric patients undergoing body-contouring procedures, and that this strategy could represent a cost-effective adjuvant treatment in body-contouring procedures. The investigators' preliminary study experience on post-bariatric obese patients undergoing an abdominoplasty and post-operatively treated with ciNPT, showed that ciNPT promotes effective and prompt wound closure minimizing peri-operative/post-operative complications in these patients. The investigators also showed that ciPNT positively impacts the length of hospitalization and the rate of secondary surgeries in these patients. Based on this successful preliminary experience, the invetsigators here propose to validate these findings in a prospective RCT.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Obesity, Morbid, Obesity, Obesity, Abdominal, Wound, Wound Infection, Wound Complication, Wound Dehiscence, Wound Contamination, Wound Heal, Wound; Abdomen, Incision, Incision Site Rash, Incision Site Bleeding, Incision Site Swelling, Incision Site Haematoma, Incision Site Infection, Incision Site Inflammation, Incision Site Complication, Incision Surgical, Surgery--Complications, Surgical Wound Infection, Surgical Site Infection, Scarring as Surgical Complication, Scar, Scarring
    Keywords
    Closed-incision negative pressure therapy, Negative pressure wound therapy, Wound care, Surgical incision, Wound complication, Dehiscence, Surgical Site Infection, Seroma, Hematoma, Wound Healing, Inflammation, Incisional Wound, Abdominoplasty, Abdominal panniculectomy, Body contouring

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    Case-control Experimental/Interventional Group: post-operative ciNPT (first 7 days) Control Group: post-operative standard wound care
    Masking
    Outcomes Assessor
    Masking Description
    Analysis of data and statistical analysis will be blinded to groups.
    Allocation
    Randomized
    Enrollment
    130 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    ciNPT group
    Arm Type
    Experimental
    Arm Description
    Subjects will receive post-operative incisional wound care by ciNPT (125 mmHg, continuous suction) for the first 7 days after surgery.
    Arm Title
    Control group
    Arm Type
    Sham Comparator
    Arm Description
    Subjects will receive post-operative incisional wound care by standard non-adherent surgical dressing (vaseline petrolatum gauze),
    Intervention Type
    Device
    Intervention Name(s)
    ciNPT group
    Other Intervention Name(s)
    ciNPT, PREVENA™ Incision Management System, closed-incision negative pressure therapy
    Intervention Description
    Closed-incision negative pressure therapy (ciNPT) will be applied for 7 day using continuous suction at 125 mmHg. To deliver ciNPT we will use a commercially available, FDA-approved device, used according to the manufacturer' indications (PREVENA™ Incision Management System (KCI, San Antonio, Texas, USA). After the first 7 post-operative days, subjects will discontinue the ciNPT and follow a standard wound care protocol.
    Intervention Type
    Other
    Intervention Name(s)
    Control group
    Other Intervention Name(s)
    Standard incisional wound care
    Intervention Description
    Standard non-adherent surgical dressing (Vaseline petrolatum gauze) will be used for management of incisional wounds in the control group. Dressing changes will be performed per standard wound care protocol.
    Primary Outcome Measure Information:
    Title
    Rate of post-surgical local complications
    Description
    The change in post-surgical local complications (Skin blistering/necrosis, Surgical Site Infections, hematoma, seroma, need for re-operation) through 30 days after surgery.
    Time Frame
    30 days
    Secondary Outcome Measure Information:
    Title
    Time-to-heal
    Description
    A change in time (days) to complete wound closure for treated groups vs. controls.
    Time Frame
    <60 days
    Title
    Scar quality: Vancouver Scar Scale
    Description
    A change in the macroscopic quality of scars at a 30 and 90 days follow up (measured with the Vancouver Scar Scale-VSS [Score range: 0-13, lower scores being a better outcome]).
    Time Frame
    30 and 90 days
    Title
    Medical costs
    Description
    A change in direct medical costs (considering cumulative costs related to: hospitalization, standard and additional post-operative care, additional surgical and medical care for complications) in the first 60 days after surgery.
    Time Frame
    60 days

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: previous bariatric surgery for weight loss candidate for/undergoing an abdominal panniculectomy (abdominoplasty) Residual BMI >30 kg/m2 at the time of the operation Evidence of pannus (abdominal) ptosis (Pittsburgh Rating Scale >2) Lipodystrophy and inelasticity of the skin Presence at the time of surgery of at least one local risk factor (e.g. a history or the presence of local complications such as skin blistering, recurrent erythema, panniculitis, or chronic infection; history of abdominal hernia or need for abdominal hernia repair) OR one systemic risk factor (diabetes, smoking habit, serum proteins below 6g/dL). Exclusion Criteria: Severe systemic co-morbidities (defined as ASA III or higher) Malignant tumors Conditions or medications affecting wound healing (e.g. steroidal drugs or keloids) Known allergies to components of the treatment Presence of severe local cutaneous complications (open wounds, extensive infections) at the time of surgery.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Silvio Abatangelo, M.D.
    Phone
    +39 (02) 97 96 3466
    Email
    caps.trial@gmail.com
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Silvio Abatangelo, M.D.
    Organizational Affiliation
    ASST Ovest Milanese
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    IPD Sharing Plan Description
    IPD will not be shared.
    Citations:
    PubMed Identifier
    29730777
    Citation
    Abatangelo S, Saporiti E, Giatsidis G. Closed Incision Negative-Pressure Therapy (ciNPT) Reduces Minor Local Complications in Post-bariatric Abdominoplasty Body Contouring: a Retrospective Case-Control Series. Obes Surg. 2018 Jul;28(7):2096-2104. doi: 10.1007/s11695-018-3279-8.
    Results Reference
    result

    Learn more about this trial

    CiNPT for Abdominoplasties in Post-bariatric Patients Study

    We'll reach out to this number within 24 hrs